1. Academic Validation
  2. High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design

High-resolution cryo-EM of the human CDK-activating kinase for structure-based drug design

  • Nat Commun. 2024 Mar 13;15(1):2265. doi: 10.1038/s41467-024-46375-9.
Victoria I Cushing 1 Adrian F Koh 2 Junjie Feng 1 Kaste Jurgaityte 3 Alexander Bondke 4 Sebastian H B Kroll 4 Marion Barbazanges 4 5 Bodo Scheiper 4 Ash K Bahl 6 Anthony G M Barrett 4 Simak Ali 7 Abhay Kotecha 8 Basil J Greber 9
Affiliations

Affiliations

  • 1 The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK.
  • 2 Materials and Structural Analysis Division, Thermo Fisher Scientific, Achtseweg Noord 5, 5651, Eindhoven, The Netherlands.
  • 3 Division of Cancer, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK.
  • 4 Department of Chemistry, Imperial College London, London, UK.
  • 5 Institut Parisien de Chimie Moléculaire, Sorbonne Université, CNRS, 4 Place Jussieu, 75252, Paris Cedex 05, France.
  • 6 Carrick Therapeutics, Nova UCD, Bellfield Innovation Park, Dublin 4, Ireland.
  • 7 Division of Cancer, Department of Surgery & Cancer, Imperial College London, Hammersmith Hospital Campus, London, UK. simak.ali@imperial.ac.uk.
  • 8 Materials and Structural Analysis Division, Thermo Fisher Scientific, Achtseweg Noord 5, 5651, Eindhoven, The Netherlands. abhay.kotecha@thermofisher.com.
  • 9 The Institute of Cancer Research, Chester Beatty Laboratories, 237 Fulham Road, London, SW3 6JB, UK. basil.greber@icr.ac.uk.
Abstract

Rational design of next-generation therapeutics can be facilitated by high-resolution structures of drug targets bound to small-molecule inhibitors. However, application of structure-based methods to macromolecules refractory to crystallization has been hampered by the often-limiting resolution and throughput of cryogenic electron microscopy (cryo-EM). Here, we use high-resolution cryo-EM to determine structures of the CDK-activating kinase, a master regulator of cell growth and division, in its free and nucleotide-bound states and in complex with 15 inhibitors at up to 1.8 Å resolution. Our structures provide detailed insight into inhibitor interactions and networks of water molecules in the active site of cyclin-dependent kinase 7 and provide insights into the mechanisms contributing to inhibitor selectivity, thereby providing the basis for rational design of next-generation therapeutics. These results establish a methodological framework for the use of high-resolution cryo-EM in structure-based drug design.

Figures
Products